메뉴 건너뛰기




Volumn 47, Issue , 2012, Pages 281-293

Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers

Author keywords

ALK; Anaplastic lymphoma kinase; Crizotinib; Drug resistance; EML4 ALK; Kinase; NSCLC; Personalized therapy; Xalkori

Indexed keywords


EID: 84866748344     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-396492-2.00019-9     Document Type: Chapter
Times cited : (14)

References (44)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.